Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via autoinjector device: results of a phase 3, randomised, double‐blind trial

2021 ◽  
Author(s):  
Timothy S. Bailey ◽  
Julie Willard ◽  
Leslie J. Klaff ◽  
Jenine Yager Stone ◽  
Anita Melgaard ◽  
...  
Keyword(s):  
Severe Hypoglycaemia ◽  
Double Blind Trial ◽  
Next Generation ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial

scholarly journals P1.01-112 Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007

2019 ◽  
Vol 14 (10) ◽  
pp. S405
Author(s):  
T. Mekhail ◽  
S. Kim ◽  
K. Kubota ◽  
M. González Del Riego ◽  
L. Wu ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
First Line ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial ◽  
Metastatic Nsclc

Fospropofol Disodium for Minimal-to-Moderate Sedation During Colonoscopy Produces Clear-Headed Recovery: Results of a Phase 3, Randomized, Double-Blind Trial

2007 ◽  
Vol 65 (5) ◽  
pp. AB367 ◽  
Author(s):  
Douglas K. Rex ◽  
Lawrence B. Cohen ◽  
Jacqueline Kline ◽  
Chao Wang
Keyword(s):  
Double Blind Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Moderate Sedation ◽  
Blind Trial

Phase 3, randomized, double-blind trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma (RCC): KEYNOTE-564

2018 ◽  
Vol 17 (2) ◽  
pp. e1156-e1157 ◽  
Author(s):  
T. Powles ◽  
T. Zhang ◽  
H. Gurney ◽  
G. Doshi ◽  
P. Cobb ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Adjuvant Treatment ◽  
Renal Cell ◽  
Double Blind Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial

A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil

Vaccine ◽  
2012 ◽  
Vol 30 (52) ◽  
pp. 7566-7572 ◽  
Author(s):  
Lily Yin Weckx ◽  
Allison Thompson ◽  
Eitan Naaman Berezin ◽  
Sonia Maria de Faria ◽  
Clovis Arns da Cunha ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Conjugate Vaccines ◽  
Pneumococcal Conjugate Vaccines ◽  
Blind Trial ◽  
Healthy Infants

scholarly journals Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S536-S536 ◽  
Author(s):  
Thomas J Walsh ◽  
Tanaya Bhowmick ◽  
Rabih Darouiche ◽  
Valerii Zaitsev ◽  
Evangelos Giamarellos-Bourboulis ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Acute Pyelonephritis ◽  
Double Blind Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial ◽  
Trial Outcomes ◽  
Tract Infections
Sign in / Sign up

Export Citation Format

Share Document